Pfenex shares rise on collaboration deal with Hospira
February 10, 2015 at 10:33 AM EST
Partners are developing a generic version of Genentech’s Lucentis eye treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|